Nanoformulation of d-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for breast cancer therapy

Integrative Biology

Volumn 3, Issue 10, 2011, Pages 993-1002

  Huang, Laiqiang ^a   Chen, Hongbo ^a   Zheng, Yi ^a   Song, Xiaosong ^a   Liu, Ranyi ^b   Liu, Kexin ^c   Zeng, Xiaowei ^a,d   Mei, Lin ^a,c  

^a TSINGHUA UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c DALIAN MEDICAL UNIVERSITY   (China)

^d NORTHEASTERN UNIVERSITY AT QINHUANGDAO   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL DERIVATIVE; ALPHA TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATE BLOCK POLY(EPSILON CAPROLACTONE RAN GLYCOLIDE); DOCETAXEL; MACROGOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG FORMULATION; DRUG SYNTHESIS; FEMALE; FLUORESCENCE; HUMAN; HUMAN CELL; MOUSE; NANOPHARMACEUTICS; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RING OPENING; SCID MOUSE; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, SCID; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; POLYESTERS; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; RANDOM ALLOCATION; TAXOIDS; VITAMIN E; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 80053622909     PISSN: 17579694     EISSN: 17579708     Source Type: Journal    
DOI: 10.1039/c1ib00026h     Document Type: Article

References (34)

1. T. Tanaka P. Decuzzi M. Cristofanilli J. H. Sakamoto E. Tasciotti F. M. Robertson et al. Nanotechnology for breast cancer therapy Biomed. Microdevices. 2009 11 1 49 63
2. K. Y. Kim Nanotechnology platforms and physiological challenges for cancer therapeutics Nanomed.: Nanotechnol., Biol. Med. 2007 3 2 103 110 (Pubitemid 46899612)
3. L. Mei Y. Zhang Y. Zheng G. Tian C. Song D. Yang et al. A novel docetaxel-loaded poly (ε-Caprolactone)/pluronic F68 nanoparticle overcoming multidrug resistance for breast cancer treatment Nanoscale Res. Lett. 2009 4 12 1530 1539
4. C. K. Lim J. Shin Y. Lee J. Kim H. Park I. Kwon et al. Heavy-atomic construction of photosensitizer nanoparticles for enhanced photodynamic therapy of cancer Small 2011 7 1 112 118
5. J. S. Almeida F. Lima S. D. Ros L. O. Bulhões L. M. de Carvalho R. C. Beck Nanostructured Systems Containing Rutin: In vitro Antioxidant Activity and Photostability Studies Nanoscale Res. Lett. 2010 5 10 1603 1610
6. S. K. Sahoo S. Parveen J. J. Panda The present and future of nanotechnology in human health care Nanomed.: Nanotechnol., Biol. Med. 2007 3 1 20 31 (Pubitemid 46428187)
7. H. Maeda J. Wu T. Sawa Y. Matsumura K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Controlled Release 2000 65 271 284 (Pubitemid 30122932)
8. W. E. Bawarski E. Chidlowsky D. J. Bharali S. A. Mousa Emerging nanopharmaceuticals Nanomed.: Nanotechnol., Biol. Med. 2008 4 4 273 282
9. K. S. Soppimath T. M. Aminabhavi A. R. Kulkarni W. E. Rudzinski Biodegradable polymeric nanoparticles as drug delivery devices J. Controlled Release 2001 70 1 20 (Pubitemid 32144788)
10. J. Davda V. Labhasetwar Characterization of nanoparticle uptake by endothelial cells Int. J. Pharm. 2002 233 51 59 (Pubitemid 34230418)
11. I. Brigger C. Dubernet P. Couvreur Nanoparticles in cancer therapy and diagnosis Adv. Drug Delivery Rev. 2002 54 631 651 (Pubitemid 35247520)
12. F. Yan C. Zhang Y. Zheng L. Mei C. Song H. Sun et al. The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity Nanomed.: Nanotechnol., Biol. Med. 2010 6 170
13. R. C. Mundargi S. Srirangarajan S. A. Agnihotri S. A. Patil S. Ravindra S. B. Setty et al. Development and evaluation of novel biodegradable microspheRes. based on poly(d,l-lactide-co-glycolide) and poly(ε- caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: In vitro and in vivo studies J. Controlled Release 2007 119 59 68 (Pubitemid 46561539)
14. Y. Zhang L. Tang L. Sun J. Bao C. Song L. Huang et al. A novel paclitaxel-loaded Poly (ε-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment Acta Biomater. 2010 6 6 2045 2052
15. M. Vert Degradable and bioresorbable polymers in surgery and in pharmacology: beliefs and facts J. Mater. Sci.: Mater. Med. 2009 20 2 437 446
16. C. G. Pitt, Poly(ε-caprolactone) and its copolymers, in Biodegradable Polymers as Drug Delivery Systems, ed., M. Chasin, and, R. Langer, Marcel Dekker, New York, 1990, pp. 71-120
17. H. Sun L. Mei C. Song X. Cui P. Wang The in vivo degradation, absorption and excretion of PCL-based implant Biomaterials 2006 27 1735 1740 (Pubitemid 41759467)
18. S. Zhou J. Xu H. Yang X. Deng Synthesis and characterization of biodegradable poly(ε-caprolactone)-polyglycolide-poly(ethylene glycol) monomethyl ether random copolymer Macromol. Mater. Eng. 2004 289 576 580
19. Y. Ma Y. Zheng K. Liu G. Tian Y. Tian L. Xu et al. Nanoparticles of poly(lactide-co-glycolide)-d-α-tocopheryl polyethylene glycol 1000 succinate random copolymer for cancer treatment Nanoscale Res. Lett. 2010 5 7 1161 9
20. H. Chen Y. Zheng G. Tian Y. Tian X. Zeng G. Liu et al. Oral delivery of DMAB-modified docetaxel-loaded PLGA-TPGS nanoparticles for cancer chemotherapy Nanoscale Res. Lett. 2011 6 1 4
21. C. X. Song H. F. Sun X. D. Feng MicrospheRes. of biodegradable block copolymer for long-acting controlled delivery of contraceptives Polym. J. 1987 19 485 491 (Pubitemid 17660164)
22. H. R. Kricheldorf T. Mang J. M. Jonte Polylactones. 1. Copolymerization of glycolide and ε-caprolactone Macromolecules 1984 17 2173 2181
23. E. M. Collnot C. Baldes M. F. Wempe R. Kappl J. Hüttermann J. A. Hyatt et al. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity Mol. Pharmaceutics 2007 4 3 465 74 (Pubitemid 46983960)
24. J. M. Dintaman J. A. Silverman Inhibition of P-glycoprotein by Dalpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) Pharm. Res. 1999 16 1550 1556 (Pubitemid 29510551)
25. H. J. Youk E. Lee M. K. Choi Y. J. Lee J. H. Chung S. H. Kim et al. Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol J. Control. Release 2005 107 43 52 (Pubitemid 41253701)
26. C. Constantinou A. Papas A. I. Constantinou Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs Int. J. Cancer 2008 123 4 739 752 (Pubitemid 352032398)
27. J. Neuzil M. Tomasetti Y. Zhao L. F. Dong M. Birringer X. F. Wang et al. Vitamin E analogs, a novel group of "mitocans," as anticancer agents: the importance of being redox-silent Mol. Pharmacol. 2007 71 5 1185 1199 (Pubitemid 46658670)
28. L. Mei H. Sun X. Jin D. Zhu R. Sun M. Zhang et al. Modified paclitaxel-loaded nanoparticles for inhibition of hyperplasia in a rabbit arterial balloon injury model Pharm. Res. 2007 24 955 962 (Pubitemid 46675396)
29. M. Birringer J. H. EyTina B. A. Salvatore J. Neuzil Vitamin E analogues as inducers of apoptosis: structure-function relation Br. J. Cancer 2003 88 1948 1955 (Pubitemid 36829673)
30. K. I. Momot P. W. Kuchel B. E. Chapman P. Deo D. Whittaker NMR study of the association of propofol with nonionic surfactants Langmuir 2003 19 2088 2095
31. Y. Ma L. Huang C. Song X. Zeng G. Liu L. Mei Nanoparticle formulation of poly(ε-caprolactone-co-lactide)-d-α-tocopheryl polyethylene glycol 1000 succinate random copolymer for cervical cancer treatment Polymer 2010 51 5952 5959
32. Y. C. Dong S. S. Feng Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs Biomaterials 2004 25 2843 2849
33. M. G. Qaddoumi H. Ueda J. Yang J. Davda V. Labhasetwar V. H. Lee et al. The characteristic and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers Pharm. Res. 2004 21 641 648 (Pubitemid 38457287)
34. J. Rejman V. Oberle I. S. Zuhorn D. Hoekstra Size-dependent internalization of particle via the pathways of clathrin- and caveolae-mediated endocytosis Biochem. J. 2004 377 Pt 1 159 169 (Pubitemid 38114443)